Gene Expression in Spontaneous Experimental Autoimmune Encephalomyelitis Is Linked to Human Multiple Sclerosis Risk Genes.
Adaptive Immunity
/ genetics
Animals
Cytokines
/ metabolism
Disease Models, Animal
Encephalomyelitis, Autoimmune, Experimental
/ genetics
Humans
Immunomodulation
/ genetics
Mice
Mice, Inbred C57BL
Mice, Transgenic
Multiple Sclerosis
/ genetics
Myelin-Oligodendrocyte Glycoprotein
/ genetics
Peptide Fragments
/ genetics
Risk
Th1 Cells
/ physiology
Transcriptome
T helper cell (Th)
experimental autoimmune encephalomyelitis (EAE)
gene expression
multiple sclerosis
myelin oligodendrocyte glycoprotein (MOG)
risk genes
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2020
2020
Historique:
received:
21
05
2020
accepted:
10
08
2020
entrez:
19
10
2020
pubmed:
20
10
2020
medline:
27
5
2021
Statut:
epublish
Résumé
Recent genome-wide association studies have identified over 230 genetic risk loci for multiple sclerosis. Current experimental autoimmune encephalomyelitis (EAE) models requiring active induction of disease may not be optimally suited for the characterization of the function of these genes. We have thus used gene expression profiling to study whether spontaneous opticospinal EAE (OSE) or MOG-induced EAE mirrors the genetic contribution to the pathogenesis of multiple sclerosis more faithfully. To this end, we compared gene expression in OSE and MOG EAE models and analyzed the relationship of both models to human multiple sclerosis risk genes and T helper cell biology. We observed stronger gene expression changes and an involvement of more pathways of the adaptive immune system in OSE than MOG EAE. Furthermore, we demonstrated a more extensive enrichment of human MS risk genes among transcripts differentially expressed in OSE than was the case for MOG EAE. Transcripts differentially expressed only in diseased OSE mice but not in MOG EAE were significantly enriched for T helper cell-specific transcripts. These transcripts are part of immune-regulatory pathways. The activation of the adaptive immune system and the enrichment of both human multiple sclerosis risk genes and T helper cell-specific transcripts were also observed in OSE mice showing only mild disease signs. These expression changes may, therefore, be indicative of processes at disease onset. In summary, more human multiple sclerosis risk genes were differentially expressed in OSE than was observed for MOG EAE, especially in T
Identifiants
pubmed: 33072080
doi: 10.3389/fimmu.2020.02165
pmc: PMC7531036
doi:
Substances chimiques
Cytokines
0
Myelin-Oligodendrocyte Glycoprotein
0
Peptide Fragments
0
myelin oligodendrocyte glycoprotein (35-55)
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2165Informations de copyright
Copyright © 2020 Faber, Kurtoic, Krishnamoorthy, Weber, Pütz, Müller-Myhsok, Weber and Andlauer.
Références
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):
pubmed: 29311122
Sci Adv. 2016 Jun 17;2(6):e1501678
pubmed: 27386562
Nat Immunol. 2011 Mar;12(3):255-63
pubmed: 21278737
J Immunol. 2009 Dec 1;183(11):7169-77
pubmed: 19890056
Nat Med. 2008 Mar;14(3):337-42
pubmed: 18278054
Cell. 2018 Sep 20;175(1):85-100.e23
pubmed: 30173916
Nat Genet. 2015 Oct;47(10):1107-1113
pubmed: 26343388
Nat Commun. 2018 Jun 19;9(1):2397
pubmed: 29921915
Brain. 2015 Apr;138(Pt 4):902-17
pubmed: 25665584
Ann Neurol. 2011 Dec;70(6):887-96
pubmed: 22190363
J Hyg (Lond). 1932 Jan;32(1):33-44
pubmed: 20475119
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10719-10724
pubmed: 28893994
Bioinformatics. 2002;18 Suppl 1:S96-104
pubmed: 12169536
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205
pubmed: 31114916
J Autoimmun. 2014 Nov;54:33-50
pubmed: 25175979
Nature. 2006 Oct 5;443(7111):574-7
pubmed: 17006452
Eur J Immunol. 1995 Jul;25(7):1951-9
pubmed: 7621871
Ther Adv Neurol Disord. 2013 May;6(3):161-73
pubmed: 23634189
Cold Spring Harb Perspect Med. 2018 Jan 2;8(1):
pubmed: 29101111
J Clin Invest. 2006 Sep;116(9):2385-92
pubmed: 16955140
Curr Protoc Immunol. 2010 Feb;Chapter 15:Unit 15.1
pubmed: 20143314
J Immunol. 2013 May 1;190(9):4525-34
pubmed: 23530149
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Sci Transl Med. 2015 May 13;7(287):287ra74
pubmed: 25972006
PLoS Genet. 2013 Nov;9(11):e1003926
pubmed: 24278027
Nature. 2011 Aug 10;476(7359):214-9
pubmed: 21833088
PLoS One. 2010 Nov 29;5(11):e15531
pubmed: 21209700
J Mol Med (Berl). 2007 Nov;85(11):1161-73
pubmed: 17569024
J Exp Med. 2013 Dec 16;210(13):2921-37
pubmed: 24323356
Nature. 2011 Oct 26;479(7374):538-41
pubmed: 22031325
Bioinformatics. 2007 Aug 15;23(16):2183-4
pubmed: 17586828
Nat Rev Immunol. 2017 Mar;17(3):179-194
pubmed: 28138136
J Autoimmun. 2015 Nov;64:13-25
pubmed: 26142251
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Bioinformatics. 2008 Jul 1;24(13):1547-8
pubmed: 18467348
Eur J Immunol. 1981 Mar;11(3):195-9
pubmed: 6165588